Cargando…
Periostin as a Biomarker in the Setting of Glomerular Diseases—A Review of the Current Literature
Chronic kidney disease (CKD) is a highly prevalent and potential progressive condition with life-threatening consequences. Glomerular diseases (glomerulopathies) are causes of CKD that are potentially amenable by specific therapies. Significant resources have been invested in the identification of n...
Autores principales: | Pană, Nicolae, Căpușă, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775428/ https://www.ncbi.nlm.nih.gov/pubmed/36551967 http://dx.doi.org/10.3390/biomedicines10123211 |
Ejemplares similares
-
Using Periostin as a Biomarker in the Treatment of Asthma
por: Izuhara, Kenji, et al.
Publicado: (2016) -
Periostin as a Biomarker of the Amniotic Membrane
por: Dobreva, Mariya P., et al.
Publicado: (2012) -
The role of periostin in kidney diseases
por: Turczyn, Agnieszka, et al.
Publicado: (2021) -
Periostin in Osteoporosis and Cardiovascular Disease
por: Pickering, Marie-Eva, et al.
Publicado: (2023) -
Erratum to “Periostin as a Biomarker of the Amniotic Membrane”
por: Dobreva, Mariya P., et al.
Publicado: (2013)